US EditionNEJM Evidence publishes results from Phase 2 BEHOLD study of UBX1325
Summary by ophthalmologytimes.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.2 Articles
2 Articles
All
Left
Center
Right
Application or function of cyclodextrin in insulin and cell delivery for efficient diabetic treatment - Pharma Excipients
Abstract Diabetes mellitus (DM) poses a significant global health challenge, with escalating prevalence rates and associated complications necessitating urgent attention. Traditional insulin delivery methods, such as multiple daily subcutaneous injections, present challenges in terms of patient compliance and efficacy. Consequently, there is a growing interest in alternative insulin delivery systems. Cyclodextrins (CDs), owing to their unique mo…
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
